Bone and joint health depend on continuous remodelling — old tissue is broken down by osteoclasts while new tissue is built by osteoblasts. As we age, this balance shifts toward net loss, accelerating after menopause in women and after age 60 in men. Cartilage similarly relies on chondrocyte renewal that slows with time and joint stress.
Osteo 3 Plus addresses these processes through three complementary peptide bioregulators. The bone peptide signals osteoblast cells to support healthy bone matrix synthesis. The cartilage peptide supports chondrocyte function and proteoglycan production within joint surfaces. The connective tissue peptide maintains the structural framework that holds bone and joint architecture together.
Clinical observation reports describe improvements in joint mobility, reduced morning stiffness and steadier bone density markers in users following 30-day cycles repeated 2–4 times per year. Best results occur when peptide use is combined with weight-bearing exercise, adequate vitamin D and K2 status, and protein intake of at least 1 g per kg body weight per day.
Recommended dose: 1–2 capsules daily on an empty stomach. Osteo 3 Plus is well tolerated and can be combined with calcium, magnesium, vitamin D3+K2 and collagen peptides for comprehensive bone-joint protocols.
Always consult your physician if you have diagnosed osteoporosis or are on bisphosphonate therapy, to coordinate integrative supplementation with prescribed treatment.
